These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 33288742)

  • 1. Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies.
    Mattsson-Carlgren N; Palmqvist S; Blennow K; Hansson O
    Nat Commun; 2020 Dec; 11(1):6252. PubMed ID: 33288742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five biomarkers from one cerebrospinal fluid sample to stage Alzheimer's disease.
    Nat Aging; 2024 May; 4(5):623-624. PubMed ID: 38594461
    [No Abstract]   [Full Text] [Related]  

  • 3. Modeling of pathological traits in Alzheimer's disease based on systemic extracellular signaling proteome.
    Britschgi M; Rufibach K; Huang SL; Clark CM; Kaye JA; Li G; Peskind ER; Quinn JF; Galasko DR; Wyss-Coray T
    Mol Cell Proteomics; 2011 Oct; 10(10):M111.008862. PubMed ID: 21742799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization of fluid-based biomarkers as endpoints in disease-modifying clinical trials for Alzheimer's disease: a systematic review.
    Oosthoek M; Vermunt L; de Wilde A; Bongers B; Antwi-Berko D; Scheltens P; van Bokhoven P; Vijverberg EGB; Teunissen CE
    Alzheimers Res Ther; 2024 Apr; 16(1):93. PubMed ID: 38678292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [On the road to biological blood diagnosis of Alzheimer's disease?].
    Delaby C; Lehmann S
    Med Sci (Paris); 2024 Apr; 40(4):351-360. PubMed ID: 38651960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Alzheimer disease biomarkers: potentially yes for clinical trials but not yet for clinical practice.
    Petersen RC; Trojanowski JQ
    JAMA; 2009 Jul; 302(4):436-7. PubMed ID: 19622825
    [No Abstract]   [Full Text] [Related]  

  • 7. Unraveling the Tau Puzzle: A Brief Discussion on Biomarkers in Alzheimer's Disease.
    Cantero-Fortiz Y; Cano A; Boada M
    J Alzheimers Dis; 2024; 100(1):41-43. PubMed ID: 38848184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Biomarkers of Neurodegenerative Disorders: A Practical Guide to Their Appropriate Use and Interpretation in Clinical Practice.
    Agnello L; Gambino CM; Ciaccio AM; Masucci A; Vassallo R; Tamburello M; Scazzone C; Lo Sasso B; Ciaccio M
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of cerebrospinal fluid and plasma biomarkers in the diagnosis of neurodegenerative disorders and mild cognitive impairment.
    Gonzalez-Cuyar LF; Sonnen JA; Montine KS; Keene CD; Montine TJ
    Curr Neurol Neurosci Rep; 2011 Oct; 11(5):455-63. PubMed ID: 21725901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.
    Lewczuk P; Riederer P; O'Bryant SE; Verbeek MM; Dubois B; Visser PJ; Jellinger KA; Engelborghs S; Ramirez A; Parnetti L; Jack CR; Teunissen CE; Hampel H; Lleó A; Jessen F; Glodzik L; de Leon MJ; Fagan AM; Molinuevo JL; Jansen WJ; Winblad B; Shaw LM; Andreasson U; Otto M; Mollenhauer B; Wiltfang J; Turner MR; Zerr I; Handels R; Thompson AG; Johansson G; Ermann N; Trojanowski JQ; Karaca I; Wagner H; Oeckl P; van Waalwijk van Doorn L; Bjerke M; Kapogiannis D; Kuiperij HB; Farotti L; Li Y; Gordon BA; Epelbaum S; Vos SJB; Klijn CJM; Van Nostrand WE; Minguillon C; Schmitz M; Gallo C; Lopez Mato A; Thibaut F; Lista S; Alcolea D; Zetterberg H; Blennow K; Kornhuber J;
    World J Biol Psychiatry; 2018 Jun; 19(4):244-328. PubMed ID: 29076399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Biomarkers of Neuronal Injury in Epilepsy Shared with Neurodegenerative Diseases.
    Negi D; Granak S; Shorter S; O'Leary VB; Rektor I; Ovsepian SV
    Neurotherapeutics; 2023 Apr; 20(3):767-778. PubMed ID: 36884195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood Biomarkers in Neurodegenerative Diseases: Implications for the Clinical Neurologist.
    Alcolea D; Beeri MS; Rojas JC; Gardner RC; Lleó A
    Neurology; 2023 Jul; 101(4):172-180. PubMed ID: 36878698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoscience enables ultrasensitive detection of Alzheimer's biomarker.
    Keating CD
    Proc Natl Acad Sci U S A; 2005 Feb; 102(7):2263-4. PubMed ID: 15703290
    [No Abstract]   [Full Text] [Related]  

  • 14. Reconsidering red blood cells as the diagnostic potential for neurodegenerative disorders.
    Yadav S; Deepika ; Moar K; Kumar A; Khola N; Pant A; Kakde GS; Maurya PK
    Biol Cell; 2024 Jul; 116(7):e2400019. PubMed ID: 38822416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SAM-Support-Based Electrochemical Sensor for Aβ Biomarker Detection of Alzheimer's Disease.
    Le PG; Le HTN; Kim HE; Cho S
    Biosensors (Basel); 2023 Aug; 13(8):. PubMed ID: 37622895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic.
    O'Bryant SE; Mielke MM; Rissman RA; Lista S; Vanderstichele H; Zetterberg H; Lewczuk P; Posner H; Hall J; Johnson L; Fong YL; Luthman J; Jeromin A; Batrla-Utermann R; Villarreal A; Britton G; Snyder PJ; Henriksen K; Grammas P; Gupta V; Martins R; Hampel H;
    Alzheimers Dement; 2017 Jan; 13(1):45-58. PubMed ID: 27870940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The path to biomarker-based diagnostic criteria for the spectrum of neurodegenerative diseases.
    Baldacci F; Mazzucchi S; Della Vecchia A; Giampietri L; Giannini N; Koronyo-Hamaoui M; Ceravolo R; Siciliano G; Bonuccelli U; Elahi FM; Vergallo A; Lista S; Giorgi FS; Hampel H
    Expert Rev Mol Diagn; 2020 Apr; 20(4):421-441. PubMed ID: 32066283
    [No Abstract]   [Full Text] [Related]  

  • 18. The Link Between Heart Failure and Neurodegeneration: Insights From Circulating Biomarkers.
    Traub J; Docherty KF; Frey A
    JACC Heart Fail; 2024 Jun; 12(6):1086-1088. PubMed ID: 38839152
    [No Abstract]   [Full Text] [Related]  

  • 19. Neuropathological Validation of Cerebrospinal Fluid Biomarkers in Neurodegenerative Diseases.
    Irwin DJ
    J Appl Lab Med; 2019 Dec; ():. PubMed ID: 31811076
    [No Abstract]   [Full Text] [Related]  

  • 20. Failure of first anti-tau antibody in Alzheimer disease highlights risks of history repeating.
    Mullard A
    Nat Rev Drug Discov; 2021 Jan; 20(1):3-5. PubMed ID: 33303932
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.